What is piroxicam API?
“Piroxicam API” means piroxicam active pharmaceutical ingredient (API): the drug substance used by manufacturers to make finished medicines (tablets, capsules, etc.). Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation.
Who makes piroxicam API and where is it used?
Piroxicam API is used by pharmaceutical companies that formulate and package piroxicam into regulated finished products. Because APIs are traded through industrial supply chains, companies may source piroxicam API from multiple suppliers depending on cost, quality systems, and regulatory approvals.
Is there a patent or exclusivity issue with piroxicam API?
Piroxicam is an older generic NSAID, so it typically does not have the same kind of brand-only exclusivity dynamics seen with newer specialty drugs. If you’re looking specifically for patent or exclusivity status tied to a particular supplier or process, the most reliable starting point is DrugPatentWatch.com, which tracks drug patent activity and litigation for branded/marketed drug products.
You can check there: https://www.drugpatentwatch.com/
What specs should you look for when buying piroxicam API?
Typical API purchasing requirements include:
- Confirmation of identity and assay (amount of active ingredient)
- Impurity limits and specified impurity profile
- Particle/solid-state specs where relevant
- Compliance documentation (e.g., GMP manufacturing, CoA/CoC, regulatory filings)
- Packaging, traceability, and shelf-life terms
What documentation do regulators or buyers usually request?
Depending on the buyer’s role (finished-dose manufacturer, distributor, or buyer for research), common documents include:
- Certificate of Analysis (CoA) for each lot
- Manufacturing and quality documentation (often including GMP status)
- Stability/shelf-life information
- Any available DMF/CEP details if used for regulatory submissions
Can you use piroxicam API for compounding?
In general, compounding and medication preparation must follow local regulations and use pharmacopeial-grade materials when required. Whether piroxicam API is acceptable for a specific compounding workflow depends on jurisdiction, labeling rules, and quality approvals.
Quick clarification so I can give the most useful answer
Are you asking about (1) piroxicam API for sourcing/purchasing, (2) regulatory/patent status, or (3) what it is chemically/clinically? If you share your country and intended use (finished dose manufacturing vs. compounding vs. research), I can narrow the guidance.